7 research outputs found
MOESM1 of Profiling of metalloprotease activities in cerebrospinal fluids of patients with neoplastic meningitis
Additional file 1. Sketch of proteases and CSF infiltration, correlation analyses, and ELISA results
Thy-1-GPI anchor redirects PrP<sup>C</sup> to the apical site.
<p>(A) Cells stably expressing PrP<sup>C</sup>WT and PrP<sup>C</sup>-GPIThy-1 were grown in Transwells for 4 to 5 days, processed for immunocytochemistry, and analyzed with confocal microscopy. YZ sections (left) and view on the membrane (right) at the level of tight junctions stained for ZO-1 (red) confirm both polarization and confluency of cells and show increased apical signal for PrP<sup>C</sup>-GPIThy-1 (green). (B) After staining with PrP 3F4 antibody under non-permeabilizing conditions, serial Z-stacks from the bottom to the top were taken. YZ sections show transversal cut through cells at the level of the dashed line in mid. PrP<sup>C</sup>-GPIThy-1 was found at the apical membrane when compared to PrP<sup>C</sup>WT. Scale bars are 10 µm. (C) Cells grown in Transwells labeled with EZ-Link Sulfo-NHS-SS-Biotin either apically (a) or basolaterally (b) were processed for Western blotting for PrP<sup>C</sup> and E-Cadherin (as control of cell polarization) in parallel. The graph (three independent experiments) shows mean percentages ± SEM of apical (a) or basolateral (b) amount of protein when compared to the total amount which is set at 100%.</p
PrP<sup>C</sup>-GPIThy-1 is glycosylated and transported to the plasma membrane.
<p>(A) Schematic presentation of GPI-anchored PrP<sup>C</sup>WT and the PrP<sup>C</sup> fusion protein with the GPI-anchor of Thy-1 (PrP<sup>C</sup>-GPIThy-1). The substitution of the GPI-anchor signal sequence (ss) of the PrP for the one of Thy-1 is indicated. (B) Western blots of PrP<sup>C</sup>WT and PrP<sup>C</sup>-GPIThy-1 stably expressed in MDCK cells. A clone with a similar expression level as PrP<sup>C</sup>WT was chosen. The glycotype of di-, mono-, and non-glycosylated PrP<sup>C</sup>-GPIThy-1 is unchanged. (C) Assessment of non-permeabilized membrane localization of PrP<sup>C</sup>WT and PrP<sup>C</sup>-GPIThy-1 by confocal microscopy shows plasma membrane localization of both proteins (scale bar is 10 µm). (D) Sucrose density gradient centrifugation of 1% Triton-X100 extraction at 4°C of PrP<sup>C</sup>WT and PrP<sup>C</sup>-GPIThy-1 cells reveal localization of both in flotillin enriched DRMs. Fractions were taken from the top (fraction 1) to the bottom (fraction 12).</p
Schematic drawing of constructs used in this study.
<p>Shown are the maps of PrP<sup>C</sup>WT, PrP<sup>C</sup>G1, PrP<sup>C</sup>G2, and PrP<sup>C</sup>G3 with N-terminal signal sequence (ss) and C-terminal GPI-anchor signal (ss GPI-anchor) (dark boxes) and the mutations introduced to delete N-gylcosylation sites.</p
Cell surface biotinylation assay confirms a role of the N-glycans in polarized sorting of PrP<sup>C</sup>.
<p>Cells were grown in Transwells for 4–5 days until fully polarized and labelled with EZ-Link Sulfo-NHS-SS-Biotin either on the apical (a) or the basolateral (b) side. Cells were processed for PrP<sup>C</sup> (recognized with the 3F4 antibody) and E-cadherin Western blotting in parallel. The graph indicates densitometric evaluation of Western blots of at least 3 independent experiments, expressed as mean percentages ± SEM apical (a) or basolateral (b) of total protein found, which is set at 100%.</p
N-glycosylation of PrP<sup>C</sup> affects polar sorting in MDCK cells.
<p>MDCK cells stably expressing PrP<sup>C</sup>WT, PrP<sup>C</sup>G1, PrP<sup>C</sup>G2 or PrP<sup>C</sup>G3 were grown in Transwells for 4 to 5 days until they were fully polarized. (A) Cells were separately stained with the 3F4 antibody (green) followed by permeabilisation and staining with an antibody against ZO-1 (red), a constituent of tight junctions, indicating the cell polarity. Confocal microscopy of a Z-stack of PrP<sup>C</sup>WT (left) at the level of tight junctions stained with ZO-1, and YZ-sections (right) of all glycomutants indicate both the integrity of the polarized monolayer and a redistribution of PrP<sup>C</sup>G1 and PrP<sup>C</sup>G2 to the apical compartment when compared to PrP<sup>C</sup>WT and PrP<sup>C</sup>G3. Localization of the apical (a) and basolateral (b) compartment is indicated. (B) After immunocytochemistry under non-permeabilising conditions with the 3F4 antibody, serial Z-stacks from the bottom to the top were taken with confocal microscopy. YZ images shows transversal cut trough cells at the mid level, marked with a dashed line. PrP<sup>C</sup>WT and PrP<sup>C</sup>G3 were mainly found in the basolateral compartment whereas PrP<sup>C</sup>G1 and PrP<sup>C</sup>G2 were mainly found in both compartments. Scale bars represent 10 µm.</p
Physiological membrane localization of PrP<sup>C</sup> glycomutants.
<p>(A) Characterization of glycomutants (PrP<sup>C</sup>G1, PrP<sup>C</sup>G2, and PrP<sup>C</sup>G3) and PrP<sup>C</sup>WT for the study by Western blot analysis, using an antibody directed against the 3F4 epitope. Clones with similar amounts of overexpressed 3F4 tagged PrP<sup>C</sup> as assessed by densitometric analysis of Western blots were used for these analyses (see graph). Relative expression of various PrP<sup>C</sup> forms is shown in percentages of PrP<sup>C</sup>WT that was set to 100%. (B) Assessment of plasma membrane (non-permeabilized) and intracellular (permeabilized) localization of PrP<sup>C</sup> glycomutants by confocal microscopy shows presence of PrP<sup>C</sup> at the plasma membrane and intracellularly (scale bar is 10 µm). (C) Assessment of DRMs localization of PrP<sup>C</sup> glycomutants by Triton X-100 extraction at 4°C and sucrose density gradient centrifugation showing correct localization of PrP<sup>C</sup> glycomutants with flotillin-positive DRM containing fractions.</p